- The funding comes through the issuance of 2,34,17,778 Series D1 compulsorily convertible cumulative preference shares and 4,09,201 equity shares.
- CureFit has also proposed to increase its authorised share capital from Rs 33 crore to Rs 34 crore to "facilitate the issuance of shares" since the "existing authorized share capital is not sufficient to accommodate such issuance," the filing said.
- CureFit's current round suggests that the company would be raising multiple sub-rounds under its Series D round.
Anand Piramal, Kris Gopalakrishnan, Accel Partners, others pouring $74 million in Mukesh Bansal’s CureFit
5 May 2019 6:30 PM GMT